Overall, our results revealed that the polymorphisms in the promoter region of MMP1, MMP3 and MMP9 when correlated with clinicopathological characteristics and survival rate have shown significant effects on the risk and progression of breast cancer, substantiated by in-silico analysis. The gene discussed is MMP9; the disease is breast cancer.